| 0 |
ANTITHYROID ARTHRITIS SYNDROME |
25 |
0.9259 |
| 1 |
THYROTOXIC MYOPATHY |
11 |
0.8462 |
| 2 |
NEONATAL THYROTOXICOSIS |
9 |
0.3750 |
| 3 |
THYROID STIMULATING IMMUNOGLOBULIN INCREASED |
20 |
0.2500 |
| 4 |
THYROTOXIC PERIODIC PARALYSIS |
30 |
0.2055 |
| 5 |
DEAFNESS PERMANENT |
40 |
0.2041 |
| 6 |
TOXIC GOITRE |
10 |
0.1639 |
| 7 |
CHOANAL ATRESIA |
16 |
0.1333 |
| 8 |
THYROTOXIC CRISIS |
139 |
0.1221 |
| 9 |
STENOTROPHOMONAS MALTOPHILIA PNEUMONIA |
8 |
0.1159 |
| 10 |
ENDOCRINE OPHTHALMOPATHY |
91 |
0.1048 |
| 11 |
APLASIA CUTIS CONGENITA |
14 |
0.0979 |
| 12 |
TOXIC NODULAR GOITRE |
12 |
0.0909 |
| 13 |
PERICARDITIS FUNGAL |
6 |
0.0909 |
| 14 |
AUTOPHONY |
6 |
0.0800 |
| 15 |
ANTI-THYROID ANTIBODY INCREASED |
10 |
0.0794 |
| 16 |
POST PROCEDURAL HYPOTHYROIDISM |
10 |
0.0472 |
| 17 |
PLASMACYTOSIS |
7 |
0.0366 |
| 18 |
INSULIN AUTOIMMUNE SYNDROME |
12 |
0.0336 |
| 19 |
HYPERTHYROIDISM |
416 |
0.0287 |
| 20 |
GINGIVITIS ULCERATIVE |
6 |
0.0279 |
| 21 |
TRI-IODOTHYRONINE INCREASED |
10 |
0.0251 |
| 22 |
THYROXINE FREE INCREASED |
16 |
0.0250 |
| 23 |
EOSINOPHILIC PLEURAL EFFUSION |
7 |
0.0235 |
| 24 |
CONGENITAL HYPOTHYROIDISM |
6 |
0.0233 |
| 25 |
EXOMPHALOS |
12 |
0.0223 |
| 26 |
LEFT-TO-RIGHT CARDIAC SHUNT |
6 |
0.0203 |
| 27 |
BASEDOW'S DISEASE |
9 |
0.0191 |
| 28 |
LOSS OF PROPRIOCEPTION |
6 |
0.0186 |
| 29 |
DEAFNESS NEUROSENSORY |
59 |
0.0179 |
| 30 |
ECTHYMA |
7 |
0.0175 |
| 31 |
TYPE V HYPERLIPIDAEMIA |
8 |
0.0165 |
| 32 |
LIP EROSION |
12 |
0.0164 |
| 33 |
EXOPHTHALMOS |
35 |
0.0163 |
| 34 |
AGRANULOCYTOSIS |
261 |
0.0140 |
| 35 |
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE |
10 |
0.0136 |
| 36 |
ANTI-THYROID ANTIBODY POSITIVE |
6 |
0.0131 |
| 37 |
GOITRE |
52 |
0.0127 |
| 38 |
SKULL MALFORMATION |
8 |
0.0124 |
| 39 |
THYROXINE FREE DECREASED |
7 |
0.0124 |
| 40 |
THYROXINE INCREASED |
8 |
0.0113 |
| 41 |
BLEEDING VARICOSE VEIN |
6 |
0.0111 |
| 42 |
GASTROINTESTINAL MUCOSAL DISORDER |
7 |
0.0107 |
| 43 |
EUSTACHIAN TUBE DYSFUNCTION |
6 |
0.0104 |
| 44 |
CENTRAL SEROUS CHORIORETINOPATHY |
7 |
0.0102 |
| 45 |
JAUNDICE CHOLESTATIC |
36 |
0.0102 |
| 46 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
25 |
0.0101 |
| 47 |
CONSCIOUSNESS FLUCTUATING |
10 |
0.0096 |
| 48 |
ISCHAEMIC HEPATITIS |
13 |
0.0095 |
| 49 |
SKIN SENSITISATION |
9 |
0.0087 |
| 50 |
PULSELESS ELECTRICAL ACTIVITY |
35 |
0.0084 |
| 51 |
TWIN PREGNANCY |
7 |
0.0083 |
| 52 |
DYSMORPHISM |
18 |
0.0076 |
| 53 |
PHYSICAL DISABILITY |
33 |
0.0075 |
| 54 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
33 |
0.0073 |
| 55 |
THYROIDECTOMY |
12 |
0.0069 |
| 56 |
PAROTITIS |
8 |
0.0069 |
| 57 |
AXIAL SPONDYLOARTHRITIS |
6 |
0.0068 |
| 58 |
CHOLESTATIC LIVER INJURY |
15 |
0.0067 |
| 59 |
THYROIDITIS |
20 |
0.0067 |
| 60 |
THYROID MASS |
25 |
0.0065 |
| 61 |
MEAN CELL VOLUME DECREASED |
10 |
0.0065 |
| 62 |
NEONATAL RESPIRATORY DISTRESS |
6 |
0.0064 |
| 63 |
VENTRICULAR DYSFUNCTION |
15 |
0.0058 |
| 64 |
POLYARTHRITIS |
30 |
0.0057 |
| 65 |
CONCOMITANT DISEASE AGGRAVATED |
35 |
0.0057 |
| 66 |
HYPOTHYROIDISM |
160 |
0.0050 |
| 67 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
43 |
0.0049 |
| 68 |
AUDITORY DISORDER |
7 |
0.0049 |
| 69 |
ESSENTIAL HYPERTENSION |
9 |
0.0049 |
| 70 |
THYROID FUNCTION TEST ABNORMAL |
20 |
0.0048 |
| 71 |
CUTANEOUS VASCULITIS |
17 |
0.0047 |
| 72 |
CARDIOGENIC SHOCK |
66 |
0.0046 |
| 73 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
27 |
0.0044 |
| 74 |
THYROID DISORDER |
68 |
0.0044 |
| 75 |
KOUNIS SYNDROME |
10 |
0.0044 |
| 76 |
INFUSION SITE RASH |
6 |
0.0044 |
| 77 |
CRYPTOCOCCOSIS |
7 |
0.0043 |
| 78 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
6 |
0.0043 |
| 79 |
ESCHERICHIA BACTERAEMIA |
10 |
0.0042 |
| 80 |
CHRONIC GASTRITIS |
9 |
0.0040 |
| 81 |
SYSTEMIC CANDIDA |
10 |
0.0040 |
| 82 |
BILIRUBIN CONJUGATED INCREASED |
9 |
0.0038 |
| 83 |
HYPERSENSITIVITY VASCULITIS |
10 |
0.0038 |
| 84 |
IMPAIRED QUALITY OF LIFE |
54 |
0.0038 |
| 85 |
EAR DISCOMFORT |
37 |
0.0036 |
| 86 |
HEPATITIS CHOLESTATIC |
21 |
0.0035 |
| 87 |
PAPILLARY THYROID CANCER |
6 |
0.0034 |
| 88 |
TONSILLITIS |
18 |
0.0034 |
| 89 |
MIXED LIVER INJURY |
10 |
0.0033 |
| 90 |
PHARYNGEAL ERYTHEMA |
7 |
0.0033 |
| 91 |
PNEUMONIA KLEBSIELLA |
6 |
0.0033 |
| 92 |
INFUSION SITE BRUISING |
7 |
0.0032 |
| 93 |
CATHETER PLACEMENT |
6 |
0.0032 |
| 94 |
AUTOIMMUNE THYROIDITIS |
12 |
0.0032 |
| 95 |
HAEMODYNAMIC INSTABILITY |
24 |
0.0031 |
| 96 |
DRUG-INDUCED LIVER INJURY |
97 |
0.0031 |
| 97 |
NASAL SEPTUM DEVIATION |
6 |
0.0031 |
| 98 |
CLONUS |
8 |
0.0029 |
| 99 |
PULMONARY ALVEOLAR HAEMORRHAGE |
16 |
0.0028 |
| 100 |
LABYRINTHITIS |
7 |
0.0028 |
| 101 |
MONOCYTE COUNT INCREASED |
10 |
0.0028 |
| 102 |
PERICARDIAL HAEMORRHAGE |
6 |
0.0027 |
| 103 |
THERAPEUTIC REACTION TIME DECREASED |
8 |
0.0027 |
| 104 |
PRODUCT USE COMPLAINT |
43 |
0.0027 |
| 105 |
ORAL DISORDER |
20 |
0.0027 |
| 106 |
INFUSION SITE SWELLING |
17 |
0.0027 |
| 107 |
IRON DEFICIENCY |
12 |
0.0027 |
| 108 |
COMPUTERISED TOMOGRAM ABNORMAL |
6 |
0.0026 |
| 109 |
DISTRIBUTIVE SHOCK |
6 |
0.0026 |
| 110 |
TINNITUS |
121 |
0.0026 |
| 111 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
7 |
0.0026 |
| 112 |
HYPERTONIA |
15 |
0.0026 |
| 113 |
DIASTOLIC DYSFUNCTION |
8 |
0.0026 |
| 114 |
EAR CONGESTION |
7 |
0.0026 |
| 115 |
INFUSION SITE INFECTION |
6 |
0.0026 |
| 116 |
RED BLOOD CELL COUNT INCREASED |
7 |
0.0025 |
| 117 |
INFUSION SITE PRURITUS |
8 |
0.0025 |
| 118 |
ACUTE PULMONARY OEDEMA |
14 |
0.0025 |
| 119 |
LYMPHOCYTE COUNT INCREASED |
8 |
0.0024 |
| 120 |
EYELID MARGIN CRUSTING |
7 |
0.0024 |
| 121 |
HYPERPARATHYROIDISM SECONDARY |
6 |
0.0024 |
| 122 |
POTENTIATING DRUG INTERACTION |
8 |
0.0024 |
| 123 |
STRABISMUS |
7 |
0.0024 |
| 124 |
ECONOMIC PROBLEM |
36 |
0.0024 |
| 125 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
12 |
0.0023 |
| 126 |
VENTRICULAR FIBRILLATION |
26 |
0.0023 |
| 127 |
ONYCHOCLASIS |
16 |
0.0023 |
| 128 |
KIDNEY TRANSPLANT REJECTION |
11 |
0.0023 |
| 129 |
SINUS BRADYCARDIA |
22 |
0.0023 |
| 130 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
8 |
0.0023 |
| 131 |
PHARYNGOLARYNGEAL PAIN |
12 |
0.0023 |
| 132 |
BLOOD CREATININE DECREASED |
7 |
0.0022 |
| 133 |
HYPERACUSIS |
8 |
0.0021 |
| 134 |
PURPURA |
19 |
0.0021 |
| 135 |
LOW BIRTH WEIGHT BABY |
17 |
0.0021 |
| 136 |
HYPERBILIRUBINAEMIA |
22 |
0.0021 |
| 137 |
LEFT VENTRICULAR HYPERTROPHY |
9 |
0.0021 |
| 138 |
DIPLOPIA |
54 |
0.0021 |
| 139 |
OCULAR ICTERUS |
9 |
0.0021 |
| 140 |
PREMATURE DELIVERY |
33 |
0.0021 |
| 141 |
DYSPNOEA AT REST |
6 |
0.0021 |
| 142 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
19 |
0.0021 |
| 143 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
16 |
0.0021 |
| 144 |
GASTROINTESTINAL NECROSIS |
6 |
0.0021 |
| 145 |
INFUSION SITE REACTION |
6 |
0.0020 |
| 146 |
TRIGEMINAL NEURALGIA |
8 |
0.0020 |
| 147 |
ACUTE HEPATIC FAILURE |
27 |
0.0020 |
| 148 |
PREMATURE BABY |
59 |
0.0020 |
| 149 |
INFUSION SITE PAIN |
25 |
0.0019 |
| 150 |
RED CELL DISTRIBUTION WIDTH INCREASED |
8 |
0.0019 |
| 151 |
CARDIAC TAMPONADE |
9 |
0.0019 |
| 152 |
POLYMYALGIA RHEUMATICA |
6 |
0.0019 |
| 153 |
ORTHOPNOEA |
6 |
0.0019 |
| 154 |
STEVENS-JOHNSON SYNDROME |
41 |
0.0018 |
| 155 |
INFUSION SITE HAEMORRHAGE |
6 |
0.0018 |
| 156 |
CARDIAC FAILURE ACUTE |
12 |
0.0018 |
| 157 |
HIGH DENSITY LIPOPROTEIN DECREASED |
6 |
0.0018 |
| 158 |
RHINITIS ALLERGIC |
8 |
0.0018 |
| 159 |
ERYSIPELAS |
9 |
0.0018 |
| 160 |
HYPERCALCAEMIA |
22 |
0.0018 |
| 161 |
HEPATIC CYST |
6 |
0.0018 |
| 162 |
ISCHAEMIA |
8 |
0.0017 |
| 163 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
49 |
0.0017 |
| 164 |
NEPHROGENIC ANAEMIA |
8 |
0.0017 |
| 165 |
APLASTIC ANAEMIA |
9 |
0.0017 |
| 166 |
HANGOVER |
6 |
0.0017 |
| 167 |
HEART DISEASE CONGENITAL |
6 |
0.0017 |
| 168 |
MATERNAL DRUGS AFFECTING FOETUS |
13 |
0.0017 |
| 169 |
BRAIN INJURY |
17 |
0.0017 |
| 170 |
SYMPTOM RECURRENCE |
10 |
0.0017 |
| 171 |
CHOLESTASIS |
32 |
0.0017 |
| 172 |
INFUSION SITE ERYTHEMA |
14 |
0.0017 |
| 173 |
TYPE 1 DIABETES MELLITUS |
10 |
0.0017 |
| 174 |
LUPUS-LIKE SYNDROME |
15 |
0.0017 |
| 175 |
TEMPERATURE INTOLERANCE |
17 |
0.0016 |
| 176 |
IRON DEFICIENCY ANAEMIA |
15 |
0.0016 |
| 177 |
HYPERVOLAEMIA |
8 |
0.0016 |
| 178 |
LIVER INJURY |
39 |
0.0016 |
| 179 |
UPPER-AIRWAY COUGH SYNDROME |
13 |
0.0016 |
| 180 |
ENTEROCOLITIS |
9 |
0.0016 |
| 181 |
VITAMIN D DEFICIENCY |
15 |
0.0015 |
| 182 |
TREATMENT NONCOMPLIANCE |
84 |
0.0015 |
| 183 |
BODY TEMPERATURE DECREASED |
15 |
0.0015 |
| 184 |
VENTRICULAR TACHYCARDIA |
25 |
0.0015 |
| 185 |
ODYNOPHAGIA |
9 |
0.0015 |
| 186 |
HEPATIC ENCEPHALOPATHY |
14 |
0.0015 |
| 187 |
BLEPHARITIS |
6 |
0.0015 |
| 188 |
YELLOW SKIN |
7 |
0.0015 |
| 189 |
FOOD POISONING |
8 |
0.0015 |
| 190 |
LIVER FUNCTION TEST INCREASED |
32 |
0.0015 |
| 191 |
SINUS TACHYCARDIA |
21 |
0.0015 |
| 192 |
TASTE DISORDER |
30 |
0.0015 |
| 193 |
ABNORMAL LOSS OF WEIGHT |
10 |
0.0015 |
| 194 |
DISABILITY |
29 |
0.0015 |
| 195 |
ECCHYMOSIS |
10 |
0.0015 |
| 196 |
HAIR DISORDER |
12 |
0.0015 |
| 197 |
CONJUNCTIVITIS |
27 |
0.0015 |
| 198 |
JAUNDICE |
39 |
0.0014 |
| 199 |
GUILLAIN-BARRE SYNDROME |
7 |
0.0014 |
| 200 |
HYPERTHERMIA |
11 |
0.0014 |
| 201 |
EAR PAIN |
28 |
0.0014 |
| 202 |
LIVE BIRTH |
12 |
0.0014 |
| 203 |
BUNDLE BRANCH BLOCK LEFT |
6 |
0.0014 |
| 204 |
PERIORBITAL SWELLING |
8 |
0.0014 |
| 205 |
PULMONARY MASS |
21 |
0.0014 |
| 206 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
35 |
0.0014 |
| 207 |
ABSCESS LIMB |
6 |
0.0014 |
| 208 |
CARDIAC ARREST |
116 |
0.0014 |
| 209 |
TORSADE DE POINTES |
11 |
0.0014 |
| 210 |
PROCTALGIA |
9 |
0.0014 |
| 211 |
PSEUDOMONAS INFECTION |
12 |
0.0014 |
| 212 |
HORDEOLUM |
6 |
0.0014 |
| 213 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
6 |
0.0014 |
| 214 |
ATRIAL FLUTTER |
11 |
0.0014 |
| 215 |
NEUTROPHIL COUNT INCREASED |
14 |
0.0014 |
| 216 |
MYASTHENIA GRAVIS |
11 |
0.0014 |
| 217 |
GINGIVAL SWELLING |
6 |
0.0014 |
| 218 |
CARDIAC FAILURE |
108 |
0.0013 |
| 219 |
CARDIOTOXICITY |
12 |
0.0013 |
| 220 |
ILEUS PARALYTIC |
6 |
0.0013 |
| 221 |
SEASONAL ALLERGY |
19 |
0.0013 |
| 222 |
ATRIAL FIBRILLATION |
130 |
0.0013 |
| 223 |
CATATONIA |
7 |
0.0013 |
| 224 |
FOETAL EXPOSURE DURING PREGNANCY |
107 |
0.0013 |
| 225 |
LIGAMENT SPRAIN |
13 |
0.0013 |
| 226 |
THERAPY NON-RESPONDER |
59 |
0.0013 |
| 227 |
IMMUNE THROMBOCYTOPENIA |
6 |
0.0013 |
| 228 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
22 |
0.0013 |
| 229 |
HYPERTRANSAMINASAEMIA |
9 |
0.0013 |
| 230 |
GENERALISED OEDEMA |
16 |
0.0013 |
| 231 |
PANCYTOPENIA |
72 |
0.0013 |
| 232 |
SEPTIC SHOCK |
56 |
0.0013 |
| 233 |
NEPHROPATHY |
12 |
0.0013 |
| 234 |
SWELLING OF EYELID |
8 |
0.0013 |
| 235 |
INTESTINAL ISCHAEMIA |
7 |
0.0013 |
| 236 |
CHOKING SENSATION |
7 |
0.0013 |
| 237 |
PULSE ABSENT |
6 |
0.0013 |
| 238 |
HYPERLIPIDAEMIA |
15 |
0.0013 |
| 239 |
SUPRAVENTRICULAR TACHYCARDIA |
12 |
0.0013 |
| 240 |
OSTEOPENIA |
19 |
0.0013 |
| 241 |
OCULAR DISCOMFORT |
14 |
0.0012 |
| 242 |
DISCOMFORT |
76 |
0.0012 |
| 243 |
ATELECTASIS |
12 |
0.0012 |
| 244 |
REBOUND EFFECT |
14 |
0.0012 |
| 245 |
MITRAL VALVE INCOMPETENCE |
14 |
0.0012 |
| 246 |
MAJOR DEPRESSION |
9 |
0.0012 |
| 247 |
GRANULOCYTOPENIA |
7 |
0.0012 |
| 248 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
31 |
0.0012 |
| 249 |
CARDIOMEGALY |
15 |
0.0012 |
| 250 |
EXERCISE TOLERANCE DECREASED |
7 |
0.0012 |
| 251 |
PHARYNGITIS |
15 |
0.0012 |
| 252 |
CAESAREAN SECTION |
14 |
0.0012 |
| 253 |
PANCREATITIS ACUTE |
27 |
0.0012 |
| 254 |
HYPERKALAEMIA |
42 |
0.0012 |
| 255 |
SPLENOMEGALY |
14 |
0.0012 |
| 256 |
HYPOKALAEMIA |
55 |
0.0012 |
| 257 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
6 |
0.0012 |
| 258 |
HEPATIC STEATOSIS |
22 |
0.0012 |
| 259 |
ENCEPHALOPATHY |
29 |
0.0012 |
| 260 |
SHOCK |
27 |
0.0012 |
| 261 |
RESPIRATION ABNORMAL |
8 |
0.0012 |
| 262 |
ADRENAL INSUFFICIENCY |
14 |
0.0012 |
| 263 |
END STAGE RENAL DISEASE |
21 |
0.0012 |
| 264 |
FOETAL GROWTH RESTRICTION |
7 |
0.0012 |
| 265 |
AUTOIMMUNE HEPATITIS |
8 |
0.0011 |
| 266 |
ACUTE RESPIRATORY FAILURE |
22 |
0.0011 |
| 267 |
LEUKOPENIA |
57 |
0.0011 |
| 268 |
GLOMERULAR FILTRATION RATE DECREASED |
14 |
0.0011 |
| 269 |
PULMONARY CONGESTION |
15 |
0.0011 |
| 270 |
TRICUSPID VALVE INCOMPETENCE |
9 |
0.0011 |
| 271 |
PULMONARY TOXICITY |
8 |
0.0011 |
| 272 |
AUTOIMMUNE DISORDER |
11 |
0.0011 |
| 273 |
HAIR TEXTURE ABNORMAL |
15 |
0.0011 |
| 274 |
FACIAL PAIN |
10 |
0.0011 |
| 275 |
COMPRESSION FRACTURE |
6 |
0.0011 |
| 276 |
ANAL FISSURE |
6 |
0.0011 |
| 277 |
VASCULITIS |
13 |
0.0011 |
| 278 |
DECUBITUS ULCER |
9 |
0.0011 |
| 279 |
GINGIVAL BLEEDING |
15 |
0.0011 |
| 280 |
FOREIGN BODY SENSATION IN EYES |
7 |
0.0011 |
| 281 |
PNEUMONIA BACTERIAL |
10 |
0.0011 |
| 282 |
BLOOD PRESSURE DIASTOLIC DECREASED |
8 |
0.0011 |
| 283 |
FOOT DEFORMITY |
12 |
0.0011 |
| 284 |
HEPATOTOXICITY |
24 |
0.0011 |
| 285 |
HEART RATE ABNORMAL |
6 |
0.0011 |
| 286 |
BLOOD UREA INCREASED |
18 |
0.0011 |
| 287 |
BLOOD BILIRUBIN INCREASED |
29 |
0.0011 |
| 288 |
RESPIRATORY FAILURE |
78 |
0.0011 |
| 289 |
ORAL CANDIDIASIS |
14 |
0.0011 |
| 290 |
HEPATIC FAILURE |
32 |
0.0011 |
| 291 |
BRADYCARDIA |
56 |
0.0011 |
| 292 |
SPUTUM DISCOLOURED |
10 |
0.0011 |
| 293 |
VITAMIN D DECREASED |
9 |
0.0011 |
| 294 |
BLOOD POTASSIUM INCREASED |
17 |
0.0010 |
| 295 |
LEFT VENTRICULAR DYSFUNCTION |
7 |
0.0010 |
| 296 |
BREAST MASS |
7 |
0.0010 |
| 297 |
CARDIAC MURMUR |
9 |
0.0010 |
| 298 |
PERICARDIAL EFFUSION |
24 |
0.0010 |
| 299 |
PLEURAL EFFUSION |
63 |
0.0010 |
| 300 |
MADAROSIS |
12 |
0.0010 |
| 301 |
OCULAR HYPERAEMIA |
49 |
0.0010 |
| 302 |
EXPOSURE DURING PREGNANCY |
64 |
0.0010 |
| 303 |
BRAIN OEDEMA |
13 |
0.0010 |
| 304 |
EYE PAIN |
58 |
0.0010 |
| 305 |
GENERALISED TONIC-CLONIC SEIZURE |
17 |
0.0010 |
| 306 |
CHRONIC KIDNEY DISEASE |
78 |
0.0010 |
| 307 |
AKATHISIA |
14 |
0.0010 |
| 308 |
SPINAL OSTEOARTHRITIS |
9 |
0.0010 |
| 309 |
EYE SWELLING |
38 |
0.0010 |
| 310 |
ELECTROCARDIOGRAM ABNORMAL |
8 |
0.0010 |
| 311 |
PRODUCT ADMINISTRATION INTERRUPTED |
8 |
0.0010 |
| 312 |
INTERNATIONAL NORMALISED RATIO INCREASED |
29 |
0.0010 |
| 313 |
JOINT EFFUSION |
7 |
0.0010 |
| 314 |
BLOOD IRON DECREASED |
12 |
0.0010 |
| 315 |
PHOTOPHOBIA |
19 |
0.0010 |
| 316 |
PRODUCT DISPENSING ERROR |
22 |
0.0010 |
| 317 |
DISEASE RECURRENCE |
48 |
0.0010 |
| 318 |
HAEMATOCRIT DECREASED |
20 |
0.0010 |
| 319 |
PULMONARY HYPERTENSION |
21 |
0.0010 |
| 320 |
SCIATICA |
16 |
0.0010 |
| 321 |
HYPOTONIA |
10 |
0.0010 |
| 322 |
ELECTROCARDIOGRAM QT PROLONGED |
36 |
0.0010 |
| 323 |
HYPOACUSIS |
43 |
0.0010 |
| 324 |
DISSEMINATED INTRAVASCULAR COAGULATION |
14 |
0.0010 |
| 325 |
LYMPHOPENIA |
14 |
0.0010 |
| 326 |
NOCTURIA |
12 |
0.0010 |
| 327 |
MUSCLE SPASMS |
181 |
0.0010 |
| 328 |
FEBRILE NEUTROPENIA |
65 |
0.0010 |
| 329 |
POLYURIA |
8 |
0.0010 |
| 330 |
BLOOD PRESSURE SYSTOLIC INCREASED |
19 |
0.0010 |
| 331 |
INTERVERTEBRAL DISC DEGENERATION |
9 |
0.0010 |
| 332 |
QUALITY OF LIFE DECREASED |
13 |
0.0010 |
| 333 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
53 |
0.0010 |
| 334 |
HAIR COLOUR CHANGES |
12 |
0.0010 |
| 335 |
FAECES SOFT |
7 |
0.0010 |
| 336 |
PNEUMONIA ASPIRATION |
24 |
0.0010 |
| 337 |
LACERATION |
9 |
0.0010 |
| 338 |
MOUTH HAEMORRHAGE |
7 |
0.0010 |
| 339 |
SENSATION OF FOREIGN BODY |
8 |
0.0009 |
| 340 |
BLOOD URINE PRESENT |
18 |
0.0009 |
| 341 |
CARDIOMYOPATHY |
14 |
0.0009 |
| 342 |
MUSCLE ATROPHY |
12 |
0.0009 |
| 343 |
CEREBRAL DISORDER |
7 |
0.0009 |
| 344 |
RESPIRATORY TRACT CONGESTION |
15 |
0.0009 |
| 345 |
BODY HEIGHT DECREASED |
10 |
0.0009 |
| 346 |
IRRITABLE BOWEL SYNDROME |
20 |
0.0009 |
| 347 |
HAEMOPTYSIS |
26 |
0.0009 |
| 348 |
PALPITATIONS |
109 |
0.0009 |
| 349 |
PSYCHOLOGICAL TRAUMA |
8 |
0.0009 |
| 350 |
HEPATITIS ACUTE |
6 |
0.0009 |
| 351 |
LIMB INJURY |
25 |
0.0009 |
| 352 |
TROPONIN INCREASED |
7 |
0.0009 |
| 353 |
AORTIC ANEURYSM |
7 |
0.0009 |
| 354 |
RENAL TUBULAR NECROSIS |
9 |
0.0009 |
| 355 |
LOCAL SWELLING |
16 |
0.0009 |
| 356 |
BEDRIDDEN |
12 |
0.0009 |
| 357 |
LUNG INFILTRATION |
8 |
0.0009 |
| 358 |
CONGENITAL ANOMALY |
7 |
0.0009 |
| 359 |
DYSPNOEA EXERTIONAL |
34 |
0.0009 |
| 360 |
APHTHOUS ULCER |
7 |
0.0009 |
| 361 |
HEPATITIS |
23 |
0.0009 |
| 362 |
PULMONARY ARTERIAL HYPERTENSION |
13 |
0.0009 |
| 363 |
SWOLLEN TONGUE |
28 |
0.0009 |
| 364 |
GASTROINTESTINAL INFLAMMATION |
7 |
0.0009 |
| 365 |
FLUID OVERLOAD |
13 |
0.0009 |
| 366 |
NEUTROPENIA |
121 |
0.0009 |
| 367 |
HEMIPARESIS |
15 |
0.0009 |
| 368 |
EMOTIONAL DISTRESS |
107 |
0.0009 |
| 369 |
CIRCULATORY COLLAPSE |
15 |
0.0009 |
| 370 |
EXOSTOSIS |
8 |
0.0009 |
| 371 |
MUSCLE DISORDER |
7 |
0.0009 |
| 372 |
OROPHARYNGEAL PAIN |
80 |
0.0009 |
| 373 |
WEIGHT FLUCTUATION |
9 |
0.0009 |
| 374 |
DEFAECATION URGENCY |
6 |
0.0009 |
| 375 |
TACHYCARDIA |
76 |
0.0009 |
| 376 |
ABNORMAL FAECES |
7 |
0.0009 |
| 377 |
DRUG EXPOSURE DURING PREGNANCY |
29 |
0.0009 |
| 378 |
ESCHERICHIA INFECTION |
7 |
0.0009 |
| 379 |
BLOOD SODIUM DECREASED |
16 |
0.0008 |
| 380 |
CLOSTRIDIUM DIFFICILE COLITIS |
9 |
0.0008 |
| 381 |
HAND FRACTURE |
6 |
0.0008 |
| 382 |
ACUTE CORONARY SYNDROME |
7 |
0.0008 |
| 383 |
DEVICE RELATED INFECTION |
13 |
0.0008 |
| 384 |
FEAR OF INJECTION |
6 |
0.0008 |
| 385 |
BONE MARROW FAILURE |
17 |
0.0008 |
| 386 |
SARS-COV-2 TEST POSITIVE |
11 |
0.0008 |
| 387 |
BRAIN FOG |
13 |
0.0008 |
| 388 |
CANDIDA INFECTION |
14 |
0.0008 |
| 389 |
SKIN LACERATION |
9 |
0.0008 |
| 390 |
PRODUCT USE IN UNAPPROVED INDICATION |
203 |
0.0008 |
| 391 |
EPISTAXIS |
61 |
0.0008 |
| 392 |
UNRESPONSIVE TO STIMULI |
21 |
0.0008 |
| 393 |
THERAPY CHANGE |
8 |
0.0008 |
| 394 |
BLOOD PRESSURE DECREASED |
54 |
0.0008 |
| 395 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0008 |
| 396 |
BLOOD MAGNESIUM DECREASED |
7 |
0.0008 |
| 397 |
MYOPATHY |
7 |
0.0008 |
| 398 |
HOSPICE CARE |
8 |
0.0008 |
| 399 |
MATERNAL EXPOSURE DURING PREGNANCY |
72 |
0.0008 |
| 400 |
FEELING DRUNK |
6 |
0.0008 |
| 401 |
PERIPHERAL COLDNESS |
11 |
0.0008 |
| 402 |
TUBULOINTERSTITIAL NEPHRITIS |
15 |
0.0008 |
| 403 |
OVARIAN CYST |
8 |
0.0008 |
| 404 |
NAIL DISORDER |
7 |
0.0008 |
| 405 |
BLOOD CALCIUM INCREASED |
7 |
0.0008 |
| 406 |
PRODUCTIVE COUGH |
38 |
0.0008 |
| 407 |
LACRIMATION INCREASED |
24 |
0.0008 |
| 408 |
PRODUCT COMMUNICATION ISSUE |
7 |
0.0008 |
| 409 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
14 |
0.0008 |
| 410 |
ACUTE KIDNEY INJURY |
121 |
0.0008 |
| 411 |
SLEEP APNOEA SYNDROME |
15 |
0.0008 |
| 412 |
INSURANCE ISSUE |
12 |
0.0008 |
| 413 |
ALOPECIA |
154 |
0.0008 |
| 414 |
WHITE BLOOD CELL COUNT INCREASED |
30 |
0.0008 |
| 415 |
GOUT |
14 |
0.0008 |
| 416 |
ROTATOR CUFF SYNDROME |
10 |
0.0008 |
| 417 |
DRUG RESISTANCE |
20 |
0.0008 |
| 418 |
OSTEOARTHRITIS |
33 |
0.0008 |
| 419 |
GASTROINTESTINAL HAEMORRHAGE |
65 |
0.0008 |
| 420 |
LOW DENSITY LIPOPROTEIN INCREASED |
6 |
0.0008 |
| 421 |
HIATUS HERNIA |
10 |
0.0008 |
| 422 |
VENTRICULAR EXTRASYSTOLES |
8 |
0.0008 |
| 423 |
PARALYSIS |
11 |
0.0008 |
| 424 |
HAEMORRHAGIC STROKE |
6 |
0.0008 |
| 425 |
ANXIETY |
218 |
0.0008 |
| 426 |
PRODUCT USE ISSUE |
143 |
0.0008 |
| 427 |
EYE DISORDER |
25 |
0.0008 |
| 428 |
CONTUSION |
73 |
0.0008 |
| 429 |
HALLUCINATION, VISUAL |
16 |
0.0008 |
| 430 |
HYPOKINESIA |
11 |
0.0008 |
| 431 |
SINUS DISORDER |
15 |
0.0008 |
| 432 |
BLOOD ALBUMIN DECREASED |
6 |
0.0008 |
| 433 |
CHOLECYSTITIS |
9 |
0.0008 |
| 434 |
GINGIVAL PAIN |
6 |
0.0008 |
| 435 |
NECK PAIN |
42 |
0.0008 |
| 436 |
DIARRHOEA HAEMORRHAGIC |
7 |
0.0007 |
| 437 |
ASCITES |
22 |
0.0007 |
| 438 |
THYROID CANCER |
9 |
0.0007 |
| 439 |
FLANK PAIN |
7 |
0.0007 |
| 440 |
AMENORRHOEA |
13 |
0.0007 |
| 441 |
HYPERGLYCAEMIA |
27 |
0.0007 |
| 442 |
HYPOCALCAEMIA |
14 |
0.0007 |
| 443 |
PHARYNGITIS STREPTOCOCCAL |
8 |
0.0007 |
| 444 |
HYPOXIA |
26 |
0.0007 |
| 445 |
FAECES DISCOLOURED |
16 |
0.0007 |
| 446 |
DYSPHONIA |
43 |
0.0007 |
| 447 |
MYALGIA |
125 |
0.0007 |
| 448 |
LYMPHADENOPATHY |
26 |
0.0007 |
| 449 |
GASTROOESOPHAGEAL REFLUX DISEASE |
59 |
0.0007 |
| 450 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
21 |
0.0007 |
| 451 |
OSTEOPOROSIS |
30 |
0.0007 |
| 452 |
WHITE BLOOD CELL COUNT DECREASED |
79 |
0.0007 |
| 453 |
FLUID RETENTION |
37 |
0.0007 |
| 454 |
HEART RATE INCREASED |
72 |
0.0007 |
| 455 |
DEAFNESS |
19 |
0.0007 |
| 456 |
BLOOD COUNT ABNORMAL |
11 |
0.0007 |
| 457 |
RESPIRATORY DISTRESS |
20 |
0.0007 |
| 458 |
AGEUSIA |
18 |
0.0007 |
| 459 |
COAGULOPATHY |
12 |
0.0007 |
| 460 |
TRANSAMINASES INCREASED |
16 |
0.0007 |
| 461 |
BLOOD PRESSURE INCREASED |
110 |
0.0007 |
| 462 |
POLLAKIURIA |
30 |
0.0007 |
| 463 |
GAIT INABILITY |
24 |
0.0007 |
| 464 |
OSTEOMYELITIS |
13 |
0.0007 |
| 465 |
MALNUTRITION |
8 |
0.0007 |
| 466 |
COELIAC DISEASE |
7 |
0.0007 |
| 467 |
BONE DISORDER |
13 |
0.0007 |
| 468 |
TYPE 2 DIABETES MELLITUS |
24 |
0.0007 |
| 469 |
WEIGHT DECREASED |
199 |
0.0007 |
| 470 |
NEUTROPHIL COUNT DECREASED |
29 |
0.0007 |
| 471 |
ANKLE FRACTURE |
11 |
0.0007 |
| 472 |
EYE INFECTION |
8 |
0.0007 |
| 473 |
HEPATOCELLULAR INJURY |
10 |
0.0007 |
| 474 |
BLOOD CREATININE INCREASED |
46 |
0.0007 |
| 475 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 476 |
SCAB |
8 |
0.0007 |
| 477 |
DRY EYE |
35 |
0.0007 |
| 478 |
SCAR |
12 |
0.0007 |
| 479 |
ALANINE AMINOTRANSFERASE INCREASED |
43 |
0.0007 |
| 480 |
SUBDURAL HAEMATOMA |
10 |
0.0007 |
| 481 |
ANURIA |
6 |
0.0007 |
| 482 |
INJURY |
49 |
0.0007 |
| 483 |
EMPHYSEMA |
7 |
0.0007 |
| 484 |
PNEUMOTHORAX |
11 |
0.0007 |
| 485 |
THROAT IRRITATION |
31 |
0.0007 |
| 486 |
ANOSMIA |
10 |
0.0007 |
| 487 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
36 |
0.0007 |
| 488 |
FLATULENCE |
39 |
0.0007 |
| 489 |
MENTAL STATUS CHANGES |
19 |
0.0007 |
| 490 |
CONDITION AGGRAVATED |
208 |
0.0007 |
| 491 |
GASTRITIS |
18 |
0.0007 |
| 492 |
IMMUNE SYSTEM DISORDER |
9 |
0.0007 |
| 493 |
NIGHT SWEATS |
22 |
0.0007 |
| 494 |
DYSURIA |
25 |
0.0007 |
| 495 |
LIMB DISCOMFORT |
21 |
0.0007 |
| 496 |
RENAL FAILURE |
90 |
0.0007 |
| 497 |
ASPARTATE AMINOTRANSFERASE INCREASED |
36 |
0.0007 |
| 498 |
DRUG ERUPTION |
12 |
0.0007 |
| 499 |
POOR VENOUS ACCESS |
7 |
0.0007 |
| 500 |
DRUG EFFECT LESS THAN EXPECTED |
10 |
0.0007 |
| 501 |
BACTERAEMIA |
8 |
0.0007 |
| 502 |
EYE DISCHARGE |
7 |
0.0007 |
| 503 |
OEDEMA PERIPHERAL |
82 |
0.0007 |
| 504 |
HERNIA |
13 |
0.0007 |
| 505 |
CARDIAC FAILURE CONGESTIVE |
54 |
0.0007 |
| 506 |
UPPER RESPIRATORY TRACT INFECTION |
31 |
0.0007 |
| 507 |
PAIN IN JAW |
19 |
0.0007 |
| 508 |
MUSCULAR WEAKNESS |
76 |
0.0007 |
| 509 |
MYOSITIS |
6 |
0.0007 |
| 510 |
POLYNEUROPATHY |
8 |
0.0007 |
| 511 |
WRIST FRACTURE |
8 |
0.0007 |
| 512 |
OROPHARYNGEAL DISCOMFORT |
6 |
0.0007 |
| 513 |
SCRATCH |
7 |
0.0007 |
| 514 |
HYPOAESTHESIA ORAL |
10 |
0.0007 |
| 515 |
ARTHRITIS |
52 |
0.0007 |
| 516 |
TOXIC EPIDERMAL NECROLYSIS |
10 |
0.0007 |
| 517 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
9 |
0.0007 |
| 518 |
INCREASED TENDENCY TO BRUISE |
6 |
0.0007 |
| 519 |
NERVOUSNESS |
34 |
0.0007 |
| 520 |
PRURITUS GENERALISED |
14 |
0.0006 |
| 521 |
HEPATIC ENZYME INCREASED |
44 |
0.0006 |
| 522 |
EJECTION FRACTION DECREASED |
10 |
0.0006 |
| 523 |
DEFORMITY |
6 |
0.0006 |
| 524 |
BLOOD TEST ABNORMAL |
9 |
0.0006 |
| 525 |
RENAL INJURY |
19 |
0.0006 |
| 526 |
ASPIRATION |
7 |
0.0006 |
| 527 |
GASTROINTESTINAL PAIN |
7 |
0.0006 |
| 528 |
MELAENA |
14 |
0.0006 |
| 529 |
CYANOSIS |
10 |
0.0006 |
| 530 |
ARRHYTHMIA |
30 |
0.0006 |
| 531 |
FOOT FRACTURE |
12 |
0.0006 |
| 532 |
ABDOMINAL PAIN LOWER |
16 |
0.0006 |
| 533 |
ABDOMINAL DISTENSION |
66 |
0.0006 |
| 534 |
RIB FRACTURE |
13 |
0.0006 |
| 535 |
TOOTH DISORDER |
14 |
0.0006 |
| 536 |
OBSTRUCTIVE AIRWAYS DISORDER |
7 |
0.0006 |
| 537 |
APHASIA |
19 |
0.0006 |
| 538 |
BURNING SENSATION |
44 |
0.0006 |
| 539 |
HEART RATE DECREASED |
22 |
0.0006 |
| 540 |
INTRAOCULAR PRESSURE INCREASED |
8 |
0.0006 |
| 541 |
BLOOD PRESSURE FLUCTUATION |
15 |
0.0006 |
| 542 |
SINUSITIS |
64 |
0.0006 |
| 543 |
RHABDOMYOLYSIS |
26 |
0.0006 |
| 544 |
CHROMATURIA |
14 |
0.0006 |
| 545 |
STATUS EPILEPTICUS |
7 |
0.0006 |
| 546 |
HEART RATE IRREGULAR |
14 |
0.0006 |
| 547 |
HYPOGLYCAEMIA |
30 |
0.0006 |
| 548 |
DIZZINESS |
308 |
0.0006 |
| 549 |
DYSSTASIA |
18 |
0.0006 |
| 550 |
GALLBLADDER DISORDER |
11 |
0.0006 |
| 551 |
IMPAIRED DRIVING ABILITY |
7 |
0.0006 |
| 552 |
HAEMORRHOIDS |
12 |
0.0006 |
| 553 |
PLATELET COUNT INCREASED |
8 |
0.0006 |
| 554 |
ANAEMIA |
117 |
0.0006 |
| 555 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 556 |
HYPOTENSION |
123 |
0.0006 |
| 557 |
NASAL CONGESTION |
36 |
0.0006 |
| 558 |
HEPATOMEGALY |
6 |
0.0006 |
| 559 |
PRODUCT SUBSTITUTION ISSUE |
35 |
0.0006 |
| 560 |
URINARY INCONTINENCE |
18 |
0.0006 |
| 561 |
ASTHENIA |
228 |
0.0006 |
| 562 |
DRUG INTERACTION |
96 |
0.0006 |
| 563 |
FEELING HOT |
37 |
0.0006 |
| 564 |
PULMONARY OEDEMA |
27 |
0.0006 |
| 565 |
THERAPY INTERRUPTED |
43 |
0.0006 |
| 566 |
BALANCE DISORDER |
52 |
0.0006 |
| 567 |
ALTERED STATE OF CONSCIOUSNESS |
13 |
0.0006 |
| 568 |
BLOOD POTASSIUM DECREASED |
18 |
0.0006 |
| 569 |
PERIPHERAL SWELLING |
92 |
0.0006 |
| 570 |
METABOLIC ACIDOSIS |
19 |
0.0006 |
| 571 |
SINUS CONGESTION |
8 |
0.0006 |
| 572 |
INFLUENZA |
66 |
0.0006 |
| 573 |
HERPES ZOSTER |
34 |
0.0006 |
| 574 |
HIP FRACTURE |
19 |
0.0006 |
| 575 |
EYELID PTOSIS |
6 |
0.0006 |
| 576 |
MACULAR DEGENERATION |
7 |
0.0006 |
| 577 |
HYPERHIDROSIS |
75 |
0.0006 |
| 578 |
FATIGUE |
453 |
0.0006 |
| 579 |
MUSCULOSKELETAL CHEST PAIN |
9 |
0.0006 |
| 580 |
THROMBOCYTOPENIA |
65 |
0.0006 |
| 581 |
DYSPHAGIA |
55 |
0.0006 |
| 582 |
BURSITIS |
7 |
0.0006 |
| 583 |
CHEST DISCOMFORT |
59 |
0.0006 |
| 584 |
INCREASED APPETITE |
11 |
0.0006 |
| 585 |
INSOMNIA |
153 |
0.0006 |
| 586 |
SEPSIS |
64 |
0.0006 |
| 587 |
APHONIA |
8 |
0.0006 |
| 588 |
POST PROCEDURAL COMPLICATION |
11 |
0.0006 |
| 589 |
ILLNESS |
59 |
0.0006 |
| 590 |
SEROTONIN SYNDROME |
11 |
0.0006 |
| 591 |
MASS |
8 |
0.0006 |
| 592 |
SKIN REACTION |
8 |
0.0006 |
| 593 |
BRONCHITIS |
42 |
0.0006 |
| 594 |
ABASIA |
14 |
0.0006 |
| 595 |
DYSKINESIA |
23 |
0.0006 |
| 596 |
LYMPHOCYTE COUNT DECREASED |
10 |
0.0006 |
| 597 |
ULCER |
9 |
0.0006 |
| 598 |
EYE PRURITUS |
19 |
0.0006 |
| 599 |
OFF LABEL USE |
495 |
0.0006 |
| 600 |
ANGIOEDEMA |
25 |
0.0006 |
| 601 |
RASH ERYTHEMATOUS |
27 |
0.0006 |
| 602 |
BACK PAIN |
131 |
0.0006 |
| 603 |
URINARY TRACT INFECTION |
96 |
0.0006 |
| 604 |
TOOTH EXTRACTION |
7 |
0.0006 |
| 605 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
27 |
0.0006 |
| 606 |
RENAL IMPAIRMENT |
47 |
0.0006 |
| 607 |
WHEEZING |
33 |
0.0006 |
| 608 |
LETHARGY |
32 |
0.0006 |
| 609 |
EYE IRRITATION |
32 |
0.0006 |
| 610 |
PARAESTHESIA ORAL |
8 |
0.0006 |
| 611 |
BACK DISORDER |
9 |
0.0006 |
| 612 |
PARAESTHESIA |
87 |
0.0006 |
| 613 |
SWELLING FACE |
36 |
0.0006 |
| 614 |
TOOTHACHE |
10 |
0.0006 |
| 615 |
BLISTER |
31 |
0.0006 |
| 616 |
BIPOLAR DISORDER |
6 |
0.0006 |
| 617 |
BACK INJURY |
6 |
0.0006 |
| 618 |
DIABETES MELLITUS |
42 |
0.0006 |
| 619 |
FLUSHING |
56 |
0.0006 |
| 620 |
PRODUCT PRESCRIBING ISSUE |
12 |
0.0006 |
| 621 |
HYPONATRAEMIA |
31 |
0.0005 |
| 622 |
CARDIO-RESPIRATORY ARREST |
23 |
0.0005 |
| 623 |
OESOPHAGITIS |
6 |
0.0005 |
| 624 |
COUGH |
154 |
0.0005 |
| 625 |
HEPATIC CYTOLYSIS |
7 |
0.0005 |
| 626 |
TREMOR |
91 |
0.0005 |
| 627 |
DECREASED APPETITE |
127 |
0.0005 |
| 628 |
PRURITUS |
210 |
0.0005 |
| 629 |
STAPHYLOCOCCAL INFECTION |
18 |
0.0005 |
| 630 |
MYDRIASIS |
7 |
0.0005 |
| 631 |
PRODUCT ADMINISTRATION ERROR |
11 |
0.0005 |
| 632 |
ABDOMINAL DISCOMFORT |
91 |
0.0005 |
| 633 |
DENTAL CARIES |
6 |
0.0005 |
| 634 |
PSYCHOMOTOR HYPERACTIVITY |
9 |
0.0005 |
| 635 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
12 |
0.0005 |
| 636 |
CONSTIPATION |
118 |
0.0005 |
| 637 |
DRY SKIN |
72 |
0.0005 |
| 638 |
DEMENTIA |
15 |
0.0005 |
| 639 |
MUSCULOSKELETAL STIFFNESS |
47 |
0.0005 |
| 640 |
BLOOD GLUCOSE INCREASED |
101 |
0.0005 |
| 641 |
WEIGHT INCREASED |
120 |
0.0005 |
| 642 |
NEURALGIA |
13 |
0.0005 |
| 643 |
DIARRHOEA |
345 |
0.0005 |
| 644 |
ARTHRALGIA |
222 |
0.0005 |
| 645 |
BLOOD CALCIUM DECREASED |
6 |
0.0005 |
| 646 |
GAIT DISTURBANCE |
102 |
0.0005 |
| 647 |
ANHEDONIA |
14 |
0.0005 |
| 648 |
HEADACHE |
334 |
0.0005 |
| 649 |
HEPATIC CIRRHOSIS |
10 |
0.0005 |
| 650 |
TOOTH INFECTION |
7 |
0.0005 |
| 651 |
PRODUCT DOSE OMISSION IN ERROR |
15 |
0.0005 |
| 652 |
MOBILITY DECREASED |
38 |
0.0005 |
| 653 |
MYOCARDIAL ISCHAEMIA |
6 |
0.0005 |
| 654 |
GASTRIC ULCER |
10 |
0.0005 |
| 655 |
THERAPY CESSATION |
27 |
0.0005 |
| 656 |
FEELING JITTERY |
10 |
0.0005 |
| 657 |
WITHDRAWAL SYNDROME |
22 |
0.0005 |
| 658 |
ANGINA PECTORIS |
15 |
0.0005 |
| 659 |
PYREXIA |
180 |
0.0005 |
| 660 |
FALL |
172 |
0.0005 |
| 661 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 662 |
DELUSION |
8 |
0.0005 |
| 663 |
JOINT INJURY |
11 |
0.0005 |
| 664 |
PNEUMONITIS |
14 |
0.0005 |
| 665 |
EOSINOPHILIA |
9 |
0.0005 |
| 666 |
IMPAIRED GASTRIC EMPTYING |
7 |
0.0005 |
| 667 |
THERAPY PARTIAL RESPONDER |
8 |
0.0005 |
| 668 |
SKIN FISSURES |
10 |
0.0005 |
| 669 |
PAIN |
314 |
0.0005 |
| 670 |
INFLUENZA LIKE ILLNESS |
42 |
0.0005 |
| 671 |
SKIN DISORDER |
17 |
0.0005 |
| 672 |
VISUAL IMPAIRMENT |
63 |
0.0005 |
| 673 |
HEAD DISCOMFORT |
9 |
0.0005 |
| 674 |
DYSPEPSIA |
50 |
0.0005 |
| 675 |
CHEST PAIN |
94 |
0.0005 |
| 676 |
ABDOMINAL PAIN |
118 |
0.0005 |
| 677 |
HYPERTENSION |
107 |
0.0005 |
| 678 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
10 |
0.0005 |
| 679 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
8 |
0.0005 |
| 680 |
HALLUCINATION |
38 |
0.0005 |
| 681 |
TRANSIENT ISCHAEMIC ATTACK |
17 |
0.0005 |
| 682 |
ORAL DISCOMFORT |
7 |
0.0005 |
| 683 |
INTERVERTEBRAL DISC PROTRUSION |
11 |
0.0005 |
| 684 |
SKIN ULCER |
13 |
0.0005 |
| 685 |
HYPOMAGNESAEMIA |
7 |
0.0005 |
| 686 |
COORDINATION ABNORMAL |
7 |
0.0005 |
| 687 |
COVID-19 |
88 |
0.0005 |
| 688 |
ABSCESS |
8 |
0.0005 |
| 689 |
ABDOMINAL PAIN UPPER |
103 |
0.0005 |
| 690 |
MYELOSUPPRESSION |
18 |
0.0005 |
| 691 |
DRUG INEFFECTIVE |
658 |
0.0005 |
| 692 |
DYSPNOEA |
282 |
0.0005 |
| 693 |
LOCALISED INFECTION |
12 |
0.0005 |
| 694 |
LIVER DISORDER |
22 |
0.0005 |
| 695 |
MUSCLE TIGHTNESS |
8 |
0.0005 |
| 696 |
RASH |
215 |
0.0005 |
| 697 |
FEEDING DISORDER |
10 |
0.0005 |
| 698 |
DRY MOUTH |
40 |
0.0005 |
| 699 |
MIGRAINE |
47 |
0.0005 |
| 700 |
INFECTION |
71 |
0.0005 |
| 701 |
CYTOPENIA |
6 |
0.0005 |
| 702 |
DELIRIUM |
17 |
0.0005 |
| 703 |
NAUSEA |
387 |
0.0005 |
| 704 |
CHOLELITHIASIS |
16 |
0.0005 |
| 705 |
CATARACT |
29 |
0.0005 |
| 706 |
MULTIPLE FRACTURES |
8 |
0.0005 |
| 707 |
INJECTION SITE EXTRAVASATION |
6 |
0.0005 |
| 708 |
PHOTOSENSITIVITY REACTION |
8 |
0.0005 |
| 709 |
BACTERIAL INFECTION |
9 |
0.0005 |
| 710 |
HEPATIC FUNCTION ABNORMAL |
18 |
0.0005 |
| 711 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 712 |
FREQUENT BOWEL MOVEMENTS |
13 |
0.0005 |
| 713 |
VISION BLURRED |
66 |
0.0005 |
| 714 |
APATHY |
7 |
0.0005 |
| 715 |
INTENTIONAL PRODUCT USE ISSUE |
42 |
0.0005 |
| 716 |
HAEMOGLOBIN DECREASED |
49 |
0.0005 |
| 717 |
VERTIGO |
29 |
0.0005 |
| 718 |
MOUTH ULCERATION |
10 |
0.0005 |
| 719 |
SKIN HAEMORRHAGE |
7 |
0.0005 |
| 720 |
URTICARIA |
79 |
0.0005 |
| 721 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
8 |
0.0005 |
| 722 |
COLON CANCER |
7 |
0.0005 |
| 723 |
DIVERTICULITIS |
13 |
0.0005 |
| 724 |
PLATELET COUNT DECREASED |
50 |
0.0005 |
| 725 |
GLAUCOMA |
9 |
0.0005 |
| 726 |
MOVEMENT DISORDER |
15 |
0.0005 |
| 727 |
ANOREXIA |
6 |
0.0005 |
| 728 |
MULTI-ORGAN FAILURE |
8 |
0.0005 |
| 729 |
PAIN IN EXTREMITY |
136 |
0.0005 |
| 730 |
DEPRESSION |
105 |
0.0005 |
| 731 |
SWELLING |
43 |
0.0005 |
| 732 |
MUCOSAL INFLAMMATION |
12 |
0.0005 |
| 733 |
CELLULITIS |
23 |
0.0005 |
| 734 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 735 |
RED BLOOD CELL COUNT DECREASED |
13 |
0.0005 |
| 736 |
ROAD TRAFFIC ACCIDENT |
19 |
0.0005 |
| 737 |
HYPERSOMNIA |
13 |
0.0005 |
| 738 |
HAEMATOCHEZIA |
25 |
0.0005 |
| 739 |
BLOOD TRIGLYCERIDES INCREASED |
8 |
0.0005 |
| 740 |
CHILLS |
53 |
0.0005 |
| 741 |
UPPER LIMB FRACTURE |
9 |
0.0005 |
| 742 |
ASTHMA |
51 |
0.0005 |
| 743 |
EAR INFECTION |
12 |
0.0005 |
| 744 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
32 |
0.0004 |
| 745 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 746 |
PNEUMONIA |
145 |
0.0004 |
| 747 |
THIRST |
8 |
0.0004 |
| 748 |
RENAL FAILURE ACUTE |
19 |
0.0004 |
| 749 |
JOINT RANGE OF MOTION DECREASED |
6 |
0.0004 |
| 750 |
PRODUCT PHYSICAL ISSUE |
9 |
0.0004 |
| 751 |
SNEEZING |
10 |
0.0004 |
| 752 |
INFLAMMATION |
23 |
0.0004 |
| 753 |
EXTRA DOSE ADMINISTERED |
18 |
0.0004 |
| 754 |
CYSTITIS |
14 |
0.0004 |
| 755 |
RESTLESSNESS |
16 |
0.0004 |
| 756 |
AGITATION |
32 |
0.0004 |
| 757 |
GASTROINTESTINAL DISORDER |
39 |
0.0004 |
| 758 |
RESPIRATORY ARREST |
12 |
0.0004 |
| 759 |
NASOPHARYNGITIS |
80 |
0.0004 |
| 760 |
HYPOPHAGIA |
11 |
0.0004 |
| 761 |
DISTURBANCE IN ATTENTION |
23 |
0.0004 |
| 762 |
DEVICE OCCLUSION |
6 |
0.0004 |
| 763 |
BLINDNESS UNILATERAL |
6 |
0.0004 |
| 764 |
CEREBROVASCULAR ACCIDENT |
72 |
0.0004 |
| 765 |
RASH GENERALISED |
11 |
0.0004 |
| 766 |
EATING DISORDER |
9 |
0.0004 |
| 767 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
15 |
0.0004 |
| 768 |
FEELING ABNORMAL |
101 |
0.0004 |
| 769 |
FUNGAL INFECTION |
14 |
0.0004 |
| 770 |
MUSCULOSKELETAL PAIN |
22 |
0.0004 |
| 771 |
SYNCOPE |
42 |
0.0004 |
| 772 |
POOR QUALITY SLEEP |
9 |
0.0004 |
| 773 |
DIABETIC KETOACIDOSIS |
10 |
0.0004 |
| 774 |
PANCREATITIS |
22 |
0.0004 |
| 775 |
HYPOAESTHESIA |
62 |
0.0004 |
| 776 |
LUNG NEOPLASM MALIGNANT |
17 |
0.0004 |
| 777 |
SKIN DISCOLOURATION |
19 |
0.0004 |
| 778 |
PRESCRIBED OVERDOSE |
8 |
0.0004 |
| 779 |
DEHYDRATION |
55 |
0.0004 |
| 780 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 781 |
C-REACTIVE PROTEIN INCREASED |
15 |
0.0004 |
| 782 |
HOT FLUSH |
31 |
0.0004 |
| 783 |
PRESYNCOPE |
10 |
0.0004 |
| 784 |
HEAD INJURY |
13 |
0.0004 |
| 785 |
MULTIPLE SCLEROSIS RELAPSE |
28 |
0.0004 |
| 786 |
PRODUCT DOSE OMISSION ISSUE |
120 |
0.0004 |
| 787 |
KIDNEY INFECTION |
8 |
0.0004 |
| 788 |
LABORATORY TEST ABNORMAL |
12 |
0.0004 |
| 789 |
OEDEMA |
22 |
0.0004 |
| 790 |
DYSGEUSIA |
30 |
0.0004 |
| 791 |
ORTHOSTATIC HYPOTENSION |
7 |
0.0004 |
| 792 |
ORAL PAIN |
9 |
0.0004 |
| 793 |
DEVICE DELIVERY SYSTEM ISSUE |
11 |
0.0004 |
| 794 |
HAEMORRHAGE INTRACRANIAL |
6 |
0.0004 |
| 795 |
THERAPEUTIC RESPONSE UNEXPECTED |
18 |
0.0004 |
| 796 |
DEVICE USE ISSUE |
7 |
0.0004 |
| 797 |
INTENTIONAL PRODUCT MISUSE |
35 |
0.0004 |
| 798 |
SPINAL FRACTURE |
8 |
0.0004 |
| 799 |
CYTOKINE RELEASE SYNDROME |
8 |
0.0004 |
| 800 |
HYPERSENSITIVITY |
74 |
0.0004 |
| 801 |
FULL BLOOD COUNT DECREASED |
8 |
0.0004 |
| 802 |
SLEEP DISORDER |
28 |
0.0004 |
| 803 |
CARDIAC DISORDER |
37 |
0.0004 |
| 804 |
PRODUCT AVAILABILITY ISSUE |
9 |
0.0004 |
| 805 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
71 |
0.0004 |
| 806 |
WOUND |
11 |
0.0004 |
| 807 |
BONE PAIN |
23 |
0.0004 |
| 808 |
OXYGEN SATURATION DECREASED |
22 |
0.0004 |
| 809 |
INJECTION SITE RASH |
12 |
0.0004 |
| 810 |
CEREBRAL HAEMORRHAGE |
14 |
0.0004 |
| 811 |
MUSCLE TWITCHING |
9 |
0.0004 |
| 812 |
MALAISE |
171 |
0.0004 |
| 813 |
INTENTIONAL OVERDOSE |
25 |
0.0004 |
| 814 |
NEUROPATHY PERIPHERAL |
37 |
0.0004 |
| 815 |
LYMPHOMA |
6 |
0.0004 |
| 816 |
LEUKOCYTOSIS |
7 |
0.0004 |
| 817 |
RHINORRHOEA |
25 |
0.0004 |
| 818 |
BLOOD CHOLESTEROL INCREASED |
18 |
0.0004 |
| 819 |
MEMORY IMPAIRMENT |
53 |
0.0004 |
| 820 |
RESPIRATORY TRACT INFECTION |
10 |
0.0004 |
| 821 |
CONFUSIONAL STATE |
62 |
0.0004 |
| 822 |
DRUG INTOLERANCE |
37 |
0.0004 |
| 823 |
ANAPHYLACTIC REACTION |
21 |
0.0004 |
| 824 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
15 |
0.0004 |
| 825 |
ABNORMAL BEHAVIOUR |
15 |
0.0004 |
| 826 |
NEEDLE ISSUE |
11 |
0.0004 |
| 827 |
SOMNOLENCE |
76 |
0.0004 |
| 828 |
OBESITY |
6 |
0.0004 |
| 829 |
RETCHING |
8 |
0.0004 |
| 830 |
MIDDLE INSOMNIA |
7 |
0.0004 |
| 831 |
LOSS OF CONSCIOUSNESS |
48 |
0.0004 |
| 832 |
IMPAIRED WORK ABILITY |
8 |
0.0004 |
| 833 |
ACUTE MYOCARDIAL INFARCTION |
11 |
0.0004 |
| 834 |
DYSARTHRIA |
14 |
0.0004 |
| 835 |
FEAR |
10 |
0.0004 |
| 836 |
INTESTINAL OBSTRUCTION |
14 |
0.0004 |
| 837 |
PAIN OF SKIN |
10 |
0.0004 |
| 838 |
PSORIATIC ARTHROPATHY |
15 |
0.0004 |
| 839 |
COLITIS |
14 |
0.0004 |
| 840 |
RESPIRATORY DISORDER |
11 |
0.0004 |
| 841 |
LUNG DISORDER |
18 |
0.0004 |
| 842 |
MOOD ALTERED |
10 |
0.0004 |
| 843 |
SKIN LESION |
10 |
0.0004 |
| 844 |
LOWER LIMB FRACTURE |
7 |
0.0004 |
| 845 |
COGNITIVE DISORDER |
17 |
0.0004 |
| 846 |
VOMITING |
171 |
0.0004 |
| 847 |
TREATMENT FAILURE |
30 |
0.0004 |
| 848 |
ERUCTATION |
7 |
0.0004 |
| 849 |
LIP SWELLING |
12 |
0.0004 |
| 850 |
URINARY RETENTION |
12 |
0.0004 |
| 851 |
FEELING COLD |
10 |
0.0004 |
| 852 |
ORAL HERPES |
7 |
0.0004 |
| 853 |
CRYING |
13 |
0.0004 |
| 854 |
PERICARDITIS |
6 |
0.0004 |
| 855 |
PANIC ATTACK |
13 |
0.0004 |
| 856 |
TOXICITY TO VARIOUS AGENTS |
60 |
0.0004 |
| 857 |
HAEMATEMESIS |
9 |
0.0004 |
| 858 |
BLOOD PRESSURE ABNORMAL |
7 |
0.0004 |
| 859 |
INTERSTITIAL LUNG DISEASE |
17 |
0.0004 |
| 860 |
HAEMATURIA |
12 |
0.0004 |
| 861 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
0.0003 |
| 862 |
THERAPEUTIC RESPONSE DECREASED |
21 |
0.0003 |
| 863 |
SEIZURE |
40 |
0.0003 |
| 864 |
SEDATION |
9 |
0.0003 |
| 865 |
SPEECH DISORDER |
18 |
0.0003 |
| 866 |
JOINT STIFFNESS |
9 |
0.0003 |
| 867 |
COLD SWEAT |
6 |
0.0003 |
| 868 |
PERITONITIS |
7 |
0.0003 |
| 869 |
GENERAL PHYSICAL HEALTH DETERIORATION |
39 |
0.0003 |
| 870 |
PRODUCT DOSE OMISSION |
22 |
0.0003 |
| 871 |
PULMONARY EMBOLISM |
32 |
0.0003 |
| 872 |
SUICIDE ATTEMPT |
20 |
0.0003 |
| 873 |
STOMATITIS |
20 |
0.0003 |
| 874 |
NEPHROLITHIASIS |
15 |
0.0003 |
| 875 |
ABNORMAL DREAMS |
9 |
0.0003 |
| 876 |
SKIN CANCER |
7 |
0.0003 |
| 877 |
SURGERY |
19 |
0.0003 |
| 878 |
PRODUCT QUALITY ISSUE |
44 |
0.0003 |
| 879 |
DEVICE LEAKAGE |
14 |
0.0003 |
| 880 |
VAGINAL HAEMORRHAGE |
14 |
0.0003 |
| 881 |
DEVICE DISLOCATION |
14 |
0.0003 |
| 882 |
SKIN EXFOLIATION |
27 |
0.0003 |
| 883 |
BLINDNESS |
13 |
0.0003 |
| 884 |
UNEVALUABLE EVENT |
24 |
0.0003 |
| 885 |
IRRITABILITY |
19 |
0.0003 |
| 886 |
INTENTIONAL DOSE OMISSION |
9 |
0.0003 |
| 887 |
PROTEINURIA |
6 |
0.0003 |
| 888 |
MUSCULOSKELETAL DISORDER |
6 |
0.0003 |
| 889 |
COLITIS ULCERATIVE |
14 |
0.0003 |
| 890 |
BLOOD GLUCOSE DECREASED |
15 |
0.0003 |
| 891 |
RASH PAPULAR |
7 |
0.0003 |
| 892 |
DRUG PRESCRIBING ERROR |
6 |
0.0003 |
| 893 |
EXPOSURE VIA SKIN CONTACT |
8 |
0.0003 |
| 894 |
AMNESIA |
20 |
0.0003 |
| 895 |
JOINT SWELLING |
37 |
0.0003 |
| 896 |
MENORRHAGIA |
6 |
0.0003 |
| 897 |
DISORIENTATION |
12 |
0.0003 |
| 898 |
RECTAL HAEMORRHAGE |
13 |
0.0003 |
| 899 |
ERYTHEMA |
62 |
0.0003 |
| 900 |
DEVICE ISSUE |
27 |
0.0003 |
| 901 |
VISUAL ACUITY REDUCED |
10 |
0.0003 |
| 902 |
ACCIDENTAL OVERDOSE |
11 |
0.0003 |
| 903 |
INJECTION SITE ERYTHEMA |
37 |
0.0003 |
| 904 |
CONTRAINDICATED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 905 |
DISEASE PROGRESSION |
35 |
0.0003 |
| 906 |
ANGER |
10 |
0.0003 |
| 907 |
RASH PRURITIC |
16 |
0.0003 |
| 908 |
EMOTIONAL DISORDER |
9 |
0.0003 |
| 909 |
GASTRIC DISORDER |
10 |
0.0003 |
| 910 |
ADVERSE DRUG REACTION |
26 |
0.0003 |
| 911 |
PROCEDURAL PAIN |
8 |
0.0003 |
| 912 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 913 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 914 |
DEPRESSED MOOD |
15 |
0.0003 |
| 915 |
LACTIC ACIDOSIS |
9 |
0.0003 |
| 916 |
HAEMORRHAGE |
29 |
0.0003 |
| 917 |
DEEP VEIN THROMBOSIS |
18 |
0.0003 |
| 918 |
ERECTILE DYSFUNCTION |
7 |
0.0003 |
| 919 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
7 |
0.0003 |
| 920 |
DEVICE BREAKAGE |
11 |
0.0003 |
| 921 |
PSYCHOTIC DISORDER |
8 |
0.0003 |
| 922 |
EXPIRED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 923 |
INJECTION SITE PRURITUS |
18 |
0.0003 |
| 924 |
CORONARY ARTERY DISEASE |
8 |
0.0003 |
| 925 |
RASH MACULAR |
9 |
0.0003 |
| 926 |
RHEUMATOID ARTHRITIS |
29 |
0.0003 |
| 927 |
NEOPLASM MALIGNANT |
17 |
0.0003 |
| 928 |
INCORRECT DOSE ADMINISTERED |
57 |
0.0002 |
| 929 |
DRUG DOSE OMISSION |
41 |
0.0002 |
| 930 |
FIBROMYALGIA |
6 |
0.0002 |
| 931 |
IMPAIRED HEALING |
8 |
0.0002 |
| 932 |
THERAPEUTIC RESPONSE SHORTENED |
8 |
0.0002 |
| 933 |
HOSPITALISATION |
37 |
0.0002 |
| 934 |
SUICIDAL IDEATION |
22 |
0.0002 |
| 935 |
COMPLETED SUICIDE |
20 |
0.0002 |
| 936 |
PSORIASIS |
31 |
0.0002 |
| 937 |
THROMBOSIS |
19 |
0.0002 |
| 938 |
RENAL DISORDER |
11 |
0.0002 |
| 939 |
ARTHROPATHY |
13 |
0.0002 |
| 940 |
MEDICATION ERROR |
13 |
0.0002 |
| 941 |
HAEMATOMA |
6 |
0.0002 |
| 942 |
NIGHTMARE |
8 |
0.0002 |
| 943 |
PLASMA CELL MYELOMA |
9 |
0.0002 |
| 944 |
MENTAL DISORDER |
10 |
0.0002 |
| 945 |
ECZEMA |
12 |
0.0002 |
| 946 |
DRUG ADMINISTRATION ERROR |
7 |
0.0002 |
| 947 |
INFUSION RELATED REACTION |
15 |
0.0002 |
| 948 |
FEMUR FRACTURE |
7 |
0.0002 |
| 949 |
MENSTRUATION IRREGULAR |
6 |
0.0002 |
| 950 |
SKIN BURNING SENSATION |
16 |
0.0002 |
| 951 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0002 |
| 952 |
MOOD SWINGS |
7 |
0.0002 |
| 953 |
DEATH |
187 |
0.0002 |
| 954 |
MALIGNANT NEOPLASM PROGRESSION |
22 |
0.0002 |
| 955 |
INCORRECT DRUG ADMINISTRATION DURATION |
6 |
0.0002 |
| 956 |
INJECTION SITE BRUISING |
17 |
0.0002 |
| 957 |
VIRAL INFECTION |
7 |
0.0002 |
| 958 |
COMA |
10 |
0.0002 |
| 959 |
ADVERSE EVENT |
19 |
0.0002 |
| 960 |
ACCIDENTAL EXPOSURE TO PRODUCT |
21 |
0.0002 |
| 961 |
ILL-DEFINED DISORDER |
12 |
0.0002 |
| 962 |
INJECTION SITE PAIN |
59 |
0.0002 |
| 963 |
NERVOUS SYSTEM DISORDER |
6 |
0.0002 |
| 964 |
INJECTION SITE MASS |
7 |
0.0002 |
| 965 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
13 |
0.0002 |
| 966 |
OSTEONECROSIS |
6 |
0.0002 |
| 967 |
DRUG DOSE OMISSION BY DEVICE |
14 |
0.0002 |
| 968 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
36 |
0.0002 |
| 969 |
NO ADVERSE EVENT |
32 |
0.0002 |
| 970 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 971 |
DEVICE MALFUNCTION |
12 |
0.0002 |
| 972 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
6 |
0.0002 |
| 973 |
MULTIPLE SCLEROSIS |
8 |
0.0002 |
| 974 |
OVERDOSE |
36 |
0.0002 |
| 975 |
UNDERDOSE |
12 |
0.0002 |
| 976 |
MYOCARDIAL INFARCTION |
28 |
0.0002 |
| 977 |
PRODUCT STORAGE ERROR |
14 |
0.0002 |
| 978 |
SKIN IRRITATION |
7 |
0.0002 |
| 979 |
DERMATITIS ATOPIC |
8 |
0.0002 |
| 980 |
ABORTION SPONTANEOUS |
6 |
0.0001 |
| 981 |
DRUG WITHDRAWAL SYNDROME |
13 |
0.0001 |
| 982 |
INJECTION SITE SWELLING |
11 |
0.0001 |
| 983 |
CONVULSION |
8 |
0.0001 |
| 984 |
INJECTION SITE HAEMORRHAGE |
11 |
0.0001 |
| 985 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 986 |
BREAST CANCER |
12 |
0.0001 |
| 987 |
RENAL CANCER |
6 |
0.0001 |
| 988 |
AGGRESSION |
6 |
0.0001 |
| 989 |
ACNE |
8 |
0.0001 |
| 990 |
INJECTION SITE REACTION |
7 |
0.0001 |
| 991 |
PROSTATE CANCER |
6 |
0.0001 |